| 注册
首页|期刊导航|中国药业|维生素K治疗神经退行性疾病的分子机制与临床研究进展

维生素K治疗神经退行性疾病的分子机制与临床研究进展

邓靖 虞燕霞

中国药业2024,Vol.33Issue(11):128,后插1-后插8,9.
中国药业2024,Vol.33Issue(11):128,后插1-后插8,9.DOI:10.3969/j.issn.1006-4931.2024.11.029

维生素K治疗神经退行性疾病的分子机制与临床研究进展

Molecular Mechanism and Clinical Research Progress of Vitamin K in the Treatment of Neurodegenerative Diseases

邓靖 1虞燕霞1

作者信息

  • 1. 南京医科大学附属苏州医院·江苏省苏州市立医院,江苏 苏州 215002
  • 折叠

摘要

Abstract

Objective To summarize the molecular mechanism and clinical research progress of vitamin K in the treatment of neurodegenerative diseases.Methods Literature analysis method was used to search literature related to vitamin K in the treatment of neurodegenerative diseases in the PubMed and CNKI databases from their inception to February 2024.The molecular mechanism of vitamin K in the treatment of neurodegenerative diseases was sorted out in terms of protein misfolding,mitochondrial dysfunction,oxidative stress,neuroinflammation,and ferroptosis.Results and Conclusion Vitamin K can improve mitochondrial function,reduce the incidence of oxidative stress,neuroinflammation,and ferroptosis,and reverse the pathological process of neurodegenerative diseases in cells or animal models by affecting the regulation of protein aggregation and autophagy.

关键词

神经退行性疾病/维生素K/神经炎症/线粒体功能/蛋白聚集/自噬/氧化应激/铁死亡

Key words

neurodegenerative diseases/vitamin K/neuroinflammation/mitochondrial function/protein aggregation/autophagy/oxidative stress/ferroptosis

分类

医药卫生

引用本文复制引用

邓靖,虞燕霞..维生素K治疗神经退行性疾病的分子机制与临床研究进展[J].中国药业,2024,33(11):128,后插1-后插8,9.

基金项目

江苏省苏州市姑苏卫生人才计划培养项目[GSWS2020062]. ()

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文